Cargando…

Drug‐Eluting Stents or Bypass Surgery for Left Main Disease: The Impact of Diabetes Mellitus

Detalles Bibliográficos
Autores principales:	Ziada, Khaled M., Powers, Eric R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428524/ https://www.ncbi.nlm.nih.gov/pubmed/32310018 http://dx.doi.org/10.1161/JAHA.120.016457

Ejemplares similares

Comparison of Bypass Surgery with Drug-Eluting Stents in Diabetic Patients with Left Main Coronary Stenosis
por: Zhao, Xiaoxiao, et al.
Publicado: (2011)

Ten‐year Outcomes After Drug‐Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow‐Up Study
por: Jeong, Yeong Jin, et al.
Publicado: (2021)

Efficacy and safety of drug-eluting stenting compared with bypass grafting in diabetic patients with multivessel and/or left main coronary artery disease
por: Xin, Xiaojun, et al.
Publicado: (2019)

Drug‐Eluting or Bare‐Metal Stents for Left Anterior Descending or Left Main Coronary Artery Revascularization
por: Piccolo, Raffaele, et al.
Publicado: (2021)

Long‐Term (10‐Year) Outcomes of Stenting or Bypass Surgery for Left Main Coronary Artery Disease in Patients With and Without Diabetes Mellitus
por: Lee, Kyusup, et al.
Publicado: (2020)

Stenting versus Bypass Surgery for the Treatment of Left Main Coronary Artery Disease
por: Park, Seung-Jung
Publicado: (2009)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
por: Wang, Xiao-Zeng, et al.
Publicado: (2015)

Long term outcomes of drug-eluting stent versus coronary artery bypass grafting for left main coronary artery disease: a meta-analysis
por: Cui, Kong-Yong, et al.
Publicado: (2018)

Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease
por: Chen, Xue, et al.
Publicado: (2020)

Percutaneous treatment of spontaneous left main coronary artery dissection using drug-eluting stent
por: Graidis, Christos, et al.
Publicado: (2014)

Five-year clinical outcomes following drug-eluting stent implantation in left main trifurcations
por: Gil, Robert J., et al.
Publicado: (2019)

Over-expansion of drug-eluting stents in patients with left main coronary artery disease: An in vivo study
por: Ye, Yicong, et al.
Publicado: (2017)

Effectiveness and Safety of Contemporary Drug-Eluting Stents in Patients With Diabetes Mellitus
por: Yang, Yujin, et al.
Publicado: (2021)

Very Long-term Safety and Effectiveness of Drug-Eluting or Bare-Metal Stents for Left Main Coronary Disease
por: Park, Hanbit, et al.
Publicado: (2021)

Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation
por: Ishihara, Takayuki, et al.
Publicado: (2020)

Percutaneous coronary intervention using drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease an updated meta-analysis of randomized clinical trials
por: Gao, Lei, et al.
Publicado: (2017)

Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials
por: Ahmad, Yousif, et al.
Publicado: (2020)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions
por: Kook, Hyungdon, et al.
Publicado: (2020)

Intravascular Ultrasound-Guided Percutaneous Coronary Intervention with Drug-eluting Stent for Unprotected Left Main Disease via Left Snuffbox Approach
por: Kim, Yongcheol, et al.
Publicado: (2018)

Successful Drug-Eluting Stent Overexpansion with Intravascular Ultrasound Guidance for Left Main Bifurcation Lesion Via Left Snuffbox Approach
por: Kim, Yongcheol, et al.
Publicado: (2019)

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
por: Tang, Xiao-Fang, et al.
Publicado: (2018)

Drug-eluting stents or coronary artery bypass grafting for unprotected left main coronary artery disease: a meta-analysis of four randomized trials and seventeen observational studies
por: Li, Qing, et al.
Publicado: (2013)

Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease
por: Papadopoulos, Kyriacos, et al.
Publicado: (2017)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
por: Paramasivam, Ganesh, et al.
Publicado: (2020)

Drug-Coated Balloon vs. Drug-Eluting Stents for De Novo Unprotected Left Main Stem Disease: The SPARTAN-LMS Study
por: Gunawardena, Tharusha D., et al.
Publicado: (2023)

Treatment of left main coronary artery stenosis with the STENTYS self-expandable drug-eluting stent – a pilot registry
por: Smolka, Grzegorz, et al.
Publicado: (2014)

Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2008)

Very Long-term Outcomes and Predictors of Percutaneous Coronary Intervention with Drug-eluting Stents Versus Coronary Artery Bypass Grafting for Patients with Unprotected Left Main Coronary Artery Disease
por: Yu, Xian-Peng, et al.
Publicado: (2016)

Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis
por: Zhao, Lin, et al.
Publicado: (2017)

New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent
por: Wang, Jian-Long, et al.
Publicado: (2018)

Clinical and conceptual approaches to interpreting the findings of systematic review and meta-analysis of mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease
por: Jayaraj, Rama, et al.
Publicado: (2020)

Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study)
por: Iannaccone, Mario, et al.
Publicado: (2020)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Corrigendum to: Clinical and Conceptual Approaches to interpreting the findings of Systematic Review and Meta-Analysis of Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease
Publicado: (2021)

Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents
por: van der Heijden, Liefke C., et al.
Publicado: (2018)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

In-Hospital Outcome of Patients with Diabetes Mellitus after CTO Recanalization with Third-Generation Drug-Eluting Stents
por: Guelker, Jan-Erik, et al.
Publicado: (2019)

Computational and experimental mechanical performance of a new everolimus-eluting stent purpose-built for left main interventions
por: Samant, Saurabhi, et al.
Publicado: (2021)

First-in-Human Computational Preprocedural Planning of Left Main Interventions Using a New Everolimus-Eluting Stent
por: Chatzizisis, Yiannis S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kkrtof8lc6i4cach7m8n3q4mlh